Extensive evaluation of a seronegative participant in an HIV-1 vaccine trial as a result of false-positive PCR

Lancet

Volumn 350, Issue 9073, 1997, Pages 256-259

  Schwartz, David H ^a   Laeyendecker, Oliver B ^a   Arango Jaramillo, Silvio ^a   Castillo, Renan C ^a   Reynolds, Mary Jane ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS RNA;

ARTICLE; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; LYMPHOCYTE PROLIFERATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VACCINATION; VIRUS DIAGNOSIS;

EID: 0030841163     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)01500-6     Document Type: Article

References (12)

1. Graham BS, Wright PF Candidate AIDS vaccines. N Engl J Med. 333:1995;1331-1339.
2. Schwartz DH, Mazumdar A, Winston S, Harkonen S Utility of various commercially available human immunodeficiency virus (HIV) antibody diagnostic kits for use in conjunction with efficacy trials of HIV-1 vaccines. Clin Diagn Lab Immunol. 2:1995;268-271.
3. Ho DD, Neuman AV, Perelson AS, Chen W, Leonard JM, Markowitz M Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 373:1995;117-122.
4. Volberding P HIV quantification: clinical applications. Lancet. 347:1996;71-73.
5. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S Rapid and simple PCR assay for quatification of HIV-1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol. 32:1994;292-300.
6. Mellors JW, Rilando CR Jr., Gupta P, White RM, Todd JA, Kingsley LA Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 272:1996;1167-1170.
7. Edelson PJ, Cohn ZA. Purification and cultivation of monocytes and macrophages. In: Bloom BA, David JR, eds. In vitro methods in cell-mediated and tumor immunity. San Diego, CA: Academic Press, 1976: 333-40.
8. Lubaki MN, Egan MA, Siliciano KJ, Bollinger RC A novel method for the detection and in vitro expansion of HIV-specific cytolytic T lymphocytes. AIDS Res Hum Retroviruses. 11:1994;1423-1429.
9. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, eds. Current protocols in immunology. Somerset, NJ: John Wiley and Sons, 1995.
10. Schwartz DH, Sharma U, Busch Met al. Absence of recoverable infectious virus and unique immune response in a long-term HIV-positive asymptomatic survivor. AIDS Res Hum Retroviruses. 10:1994;1703-1711.
11. Redfield RR, Birx DL, Ketter Net al. A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. N Engl J Med. 324:1991;1677-1684.
12. 3. Int Conf AIDS 1993; 9: 491 (abstr PO-B27-2137).